Tiny Gem Archives - Page 40 of 48

TuesdaySep 06, 2022 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Quest to Find Hypertension Treatment Promising With DehydraTECH(TM)’s Ability to Boost Bioavailability

Lexaria, a global innovator of drug delivery platforms is looking to provide a FDA registered hypertension treatment with its patented DehydraTECH technologyThe company’s efforts are encapsulated in its DehydraTECH-CBD that has been shown to lower blood pressure as well as reduce arterial stiffnessAlthough hypertension is a devastating condition that can cause not only life-threatening illnesses but also death, only about 53% of Americans with the condition have it under controlA Harvard Health article notes that the remaining portion (47%) are not able to control the disease because they are discouraged by medications’ side effectsLexaria’s DehydraTECH-CBD may well be the solution…

FridaySep 02, 2022 9:15 am

B2B iGaming Leader Golden Matrix Group Inc. (NASDAQ: GMGI) To Enter B2C Market with Recent Permit Approval

GMGI acquired 80% stake in RKings social gaming platform that earned $32 million in revenue and $2.6 million in net income during fiscal 2021Permit application for Mexico approved others to follow as more governments legalize online gamblingOnline gambling revenues expected to reach $153.6 billion by 2030 at CAGR of 11.7 percent from 2022 to 2030 Golden Matrix Group (NASDAQ: GMGI), an iGaming leader based in Las Vegas, develops, and owns online gaming IP, turnkey online casino solutions, and configurable, scalable white-label gaming platforms for international gaming operators. The company’s extensive portfolio of proprietary technology has made it a leader in…

ThursdaySep 01, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), Moving the Needle in GBM and Brain Cancer Research

When CNS went public in 2019, the funds went primarily into pre-clinical preparation, trial design approval, and drug manufacturing for its potentially pivotal global clinical trial of Berubicin for recurrent glioblastoma multiforme (“GBM”)So far, CNS has received FDA Fast Track Designation on its Berubicin clinical study, inching the company closer to offering a viable solution to the millions of people dealing with GBM, a devastating malignant brain cancerIt remains committed to pushing the envelope in terms of research and development of potential GBM treatment, as we ll as brain cancers in general, to offer a viable solution to patients and…

WednesdayAug 31, 2022 11:30 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Pioneering Efforts as Studies, Research Show Psilocybin’s Potential in Treating AUD

A new study shows promise in treating alcohol addiction with psychedelic mushroom compound, psilocybinThese results align with efforts and expectations of Cybin, a leading ethical biopharmaceutical company championing psilocybinAfter receiving FDA approval, the company is moving forward with a first-in-human clinical trial evaluating CYB003 A new study published in JAMA Psychiatry offers hope for those struggling with alcoholism (https://ibn.fm/jV5o9), showing promise in treating alcohol addiction with the psychedelic compound psilocybin. This news aligns with initiatives of Cybin (NEO: CYBN) (NYSE American: CYBN), a leading ethical biopharmaceutical company, which has a drug in development, CYB003, for the treatment of alcohol use disorder…

WednesdayAug 31, 2022 9:15 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Set to Capitalize on US Online Gaming Boom

Commercial gaming revenues in the United States reached a record $14.81bn in 2Q22Online gaming operations grew at an even faster pace, rising by 34.3% YoY to all-time high of $1.21 billionRecent studies have found that the online gaming market space within the United States could triple in size over the next five years, growing to $24.3 billion by 2026Golden Matrix Group, which recently won its Mexican gaming permit, looks well positioned to capitalize on the growth of the US online gaming sector through its B2B white-labelling operations Commercial gaming revenue in the United States reached a record $14.81 billion in…

TuesdayAug 30, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Looking to Fill Glioblastoma Multiforme Treatment Gap with Berubicin Drug Product

CNS Pharmaceuticals is currently undertaking a potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine administered after first-line therapy for the treatment of recurrent glioblastoma multiforme (“GBM”)GBM is an aggressive form of cancer that occurs in the brain or spinal cordIn the U.S., it affects between 12,000-15,000 new patients annually with a median survival rate of only 14.6 months from its diagnosisCNS’s drug development program is targeting the GBM drug market which is expected to expand at a CAGR of more than 4% between 2020 and 2030 On July 24, 2021, pre-clinical stage biotechnology company…

FridayAug 26, 2022 9:45 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leading Out in Transformation of Psychedelic Sector

Psilocybin is seeing a “research resurgence” focused on how the substance changes the brain's connectivity patternsCYBN is leading the industry in developing proprietary psychedelic-based therapeuticsThe company’s lead investigational molecule has the potential to treat major depressive disorder and alcohol use disorder The status of psilocybin is evolving as a result of mounting public acceptance and growing evidence that the substance delivers remarkable health benefits. Cybin (NEO: CYBN) (NYSE American: CYBN) is on the leading edge of this transformation, as the clinical-stage biopharmaceutical company focuses on progressing psychedelics to therapeutics by offering a new standard of care for mental-health disorders and improving…

FridayAug 26, 2022 9:00 am

Golden Matrix Group Inc. (NASDAQ: GMGI) Scores Big Q3 Win on International Expansion

GMGI sets new bar for quarterly revenue, topping $9 million for first timeThe company currently has a string of 15 consecutive profitable quartersGolden Matrix is growing through international M&A activity and launching gaming products, including a new highly anticipated eSports platform Tech stocks have rallied since the tech-laden Nasdaq hit a nearly two-year low in June. Most of the first half of the year was dominated by geopolitical drama, and international upheaval fueling recession concerns amid spiking inflation. None of that stopped Golden Matrix Group (NASDAQ: GMGI) from having its best revenue quarter ever, spearheaded by horizontal and vertical growth.…

FridayAug 19, 2022 9:00 am

Cepton, Inc. (NASDAQ: CPTN) Sees Lidar’s Uses Expand, Maintaining Accuracy and Safety Above All

US traffic-related fatalities touched a 16-year high in 2021, outstripping other major economies across the WorldThe US Collision Industry Conference has forecast crash rates to decline by as much as 20% by 2030 on the back of widespread ADAS adoptionCepton has pioneered the use of lidar, a key sensor technology, across automotive and smart infrastructure applications. In 2019, the company was the recipient of the single largest ADAS lidar series production award with Koito on the General Motors business Cepton has now seen its lidar technology expand far beyond its initial intended use, ranging from revisioning public venues and commercial buildings…

WednesdayAug 17, 2022 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Grows its Product Offering; Looks to Reinforce Business Relationships in Mexico with Scheduled CFDI 4.0 Launch

Freight Technologies Inc., often abbreviated as Fr8Tech, has seen the introduction of a unique solutions suite designed to optimize and automate the supply chain process and provide a platform for B2B cross-border shipping in the NAFTA region Hudson Capital Inc. acquired 100% of Freight App, Inc. as a wholly owned subsidiary on February 14, 2022, and Fr8App (a “DBA” for Freight App, Inc.) is not only a DBA name, it is their core marketplace (a service or platform under the Freight Technologies umbrella) (https://ibn.fm/mZnwe)Fr8App, the company’s flagship product and platform for cross-border shipping, offers a cloud-based marketplace that simplifies the once-complex…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Category: Tiny Gem